These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14565650)

  • 21. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A; Iannucci A; Dager WE
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial.
    Abdelkefi A; Ben Othman T; Kammoun L; Chelli M; Romdhane NB; Kriaa A; Ladeb S; Torjman L; Lakhal A; Achour W; Ben Hassen A; Hsaïri M; Ladeb F; Ben Abdeladhim A
    Thromb Haemost; 2004 Sep; 92(3):654-61. PubMed ID: 15351864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for upper extremity venous thrombosis associated with peripherally inserted central venous catheters.
    Marnejon T; Angelo D; Abu Abdou A; Gemmel D
    J Vasc Access; 2012; 13(2):231-8. PubMed ID: 22266584
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cohort Study: Central Venous Catheter-Related Complications in Children with Hematologic Diseases at a Single Center.
    Pektaş A; Kara A; Gurgey A
    Turk J Haematol; 2015 Jun; 32(2):144-51. PubMed ID: 26316482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanical and infective central venous catheter-related complications: a prospective non-randomized study using Hickman and Groshong catheters in children with hematological malignancies.
    Biagi E; Arrigo C; Dell'Orto MG; Balduzzi A; Pezzini C; Rovelli A; Masera G; Silvestri D; Uderzo C
    Support Care Cancer; 1997 May; 5(3):228-33. PubMed ID: 9176970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis prophylaxis in patient populations with a central venous catheter: a systematic review.
    Klerk CP; Smorenburg SM; Büller HR
    Arch Intern Med; 2003 Sep; 163(16):1913-21. PubMed ID: 12963564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripherally inserted central catheters for long-term parenteral nutrition in infants with intestinal failure.
    Piper HG; de Silva NT; Amaral JG; Avitzur Y; Wales PW
    J Pediatr Gastroenterol Nutr; 2013 May; 56(5):578-81. PubMed ID: 23221995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central venous catheterization in pediatric patients affected by hematological malignancies.
    Cogliati AA; Dell'Utri D; Picardi A; Testi AM; Micozzi A; Pasotti E; Rosa G
    Haematologica; 1995; 80(5):448-50. PubMed ID: 8566889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prophylaxis of port system-associated thromboses in advanced oncology patients using heparin flushing.
    Lersch C; Kotowa W; Fung S; Janssen D
    J Cancer Res Clin Oncol; 2004 Apr; 130(4):235-41. PubMed ID: 14760527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of indwelling central venous catheter-related complications in children with broviac or clampless valved catheters.
    Fratino G; Molinari AC; Mazzola C; Giacchino M; Saracco P; Bertocchi E; Castagnola E
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):657-61. PubMed ID: 12439039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No effect of nadroparin prophylaxis in the prevention of central venous catheter (CVC)-associated thrombosis in bone marrow transplant recipients.
    Lagro SW; Verdonck LF; Borel Rinkes IH; Dekker AW
    Bone Marrow Transplant; 2000 Nov; 26(10):1103-6. PubMed ID: 11108310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of bacteremia in patients with hematological and other malignancies after initial placement of a central venous catheter.
    Pedersen G; Nørgaard M; Kiiveri M; Schønheyder HC; Larsson H; Stolberg E; Andersen PW; Sørensen HT
    J Long Term Eff Med Implants; 2007; 17(4):303-11. PubMed ID: 19267685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of venous port systems in oncology: a review of current evidence.
    Vescia S; Baumgärtner AK; Jacobs VR; Kiechle-Bahat M; Rody A; Loibl S; Harbeck N
    Ann Oncol; 2008 Jan; 19(1):9-15. PubMed ID: 17846025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.